{"name": "Chroma Therapeutics", "permalink": "chroma-therapeutics", "crunchbase_url": "http://www.crunchbase.com/company/chroma-therapeutics", "homepage_url": "http://www.chromatherapeutics.com/", "blog_url": "", "blog_feed_url": "", "twitter_username": "", "category_code": "biotech", "number_of_employees": null, "founded_year": null, "founded_month": null, "founded_day": null, "deadpooled_year": null, "deadpooled_month": null, "deadpooled_day": null, "deadpooled_url": null, "tag_list": "", "alias_list": "Chroma Therapeutics Ltd.", "email_address": "pa@chromatherapeutics.com", "phone_number": "44-(0)1235-829120", "description": "cancer and inflammation treatments", "created_at": "Tue Jul 07 20:28:36 UTC 2009", "updated_at": "Tue Apr 20 05:38:56 UTC 2010", "overview": "\u003Cp\u003EChroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. Chroma is the first company to systematically assemble intellectual property in chromatin biology and has established a strong network of academic collaborators. Chroma aims to build substantial shareholder value through the creation of a broad and innovative product pipeline aimed at the treatment of high-prevalence cancers and inflammatory disorders.\u003C/p\u003E", "image":  {"available_sizes":    [[[150,       52],      "assets/images/resized/0005/2160/52160v1-max-150x150.jpg"],     [[250,       87],      "assets/images/resized/0005/2160/52160v1-max-250x250.jpg"],     [[257,       90],      "assets/images/resized/0005/2160/52160v1-max-450x450.jpg"]],   "attribution": null}, "products":  [], "relationships":  [], "competitions":  [], "providerships":  [], "total_money_raised": "$77.5M", "funding_rounds":  [{"round_code": "unattributed",    "source_url": "",    "source_description": "Capital Report Index",    "raised_amount": 24500000.0,    "raised_currency_code": "USD",    "funded_year": 2009,    "funded_month": 6,    "funded_day": 23,    "investments":     [{"company": null,       "financial_org":        {"name": "Abingworth",         "permalink": "abingworth-management"},       "person": null},      {"company": null,       "financial_org":        {"name": "Essex Woodlands Health Ventures",         "permalink": "essex-woodlands-health-ventures"},       "person": null},      {"company": null,       "financial_org":        {"name": "Gilde IT Fund",         "permalink": "gilde-it-fund"},       "person": null},      {"company": null,       "financial_org":        {"name": "Wellcome Trust",         "permalink": "wellcome-trust"},       "person": null},      {"company":        {"name": "GlaxoSmithKline",         "permalink": "glaxosmithkline"},       "financial_org": null,       "person": null},      {"company": null,       "financial_org":        {"name": "Nomura",         "permalink": "nomura"},       "person": null}]},   {"round_code": "c",    "source_url": "http://www.chromatherapeutics.com/press-releases/Press-Release-7.pdf",    "source_description": "CHROMA THERAPEUTICS COMPLETES $53 MILLION SERIES C FINANCING",    "raised_amount": 53000000.0,    "raised_currency_code": "USD",    "funded_year": 2006,    "funded_month": 4,    "funded_day": 3,    "investments":     [{"company": null,       "financial_org":        {"name": "Nomura Phase4 Ventures",         "permalink": "nomura-phase4-ventures"},       "person": null},      {"company": null,       "financial_org":        {"name": "Abingworth",         "permalink": "abingworth-management"},       "person": null},      {"company": null,       "financial_org":        {"name": "Essex Woodlands Health Ventures",         "permalink": "essex-woodlands-health-ventures"},       "person": null},      {"company": null,       "financial_org":        {"name": "Gilde Healthcare Partners",         "permalink": "gilde-healthcare-partners"},       "person": null},      {"company": null,       "financial_org":        {"name": "The Welcom Trust",         "permalink": "the-welcom-trust"},       "person": null}]}], "investments":  [], "acquisition": null, "acquisitions":  [], "offices":  [{"description": "",    "address1": "93 Milton Park ",    "address2": "Abingdon ",    "zip_code": "OX14 4RY ",    "city": "Oxon ",    "state_code": null,    "country_code": "GBR",    "latitude": null,    "longitude": null}], "milestones":  [], "ipo": null, "video_embeds":  [], "screenshots":  [{"available_sizes":     [[[150,        120],       "assets/images/resized/0006/3756/63756v1-max-150x150.jpg"],      [[250,        200],       "assets/images/resized/0006/3756/63756v1-max-250x250.jpg"],      [[450,        360],       "assets/images/resized/0006/3756/63756v1-max-450x450.jpg"]],    "attribution": null}], "external_links":  []}